$CING
Cingulate Inc.

2022 Q3 Form 10-Q Financial Statement

#000149315222021964 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.845M $1.871M $2.247M
YoY Change -83.05% 33.93% 192.72%
% of Gross Profit
Research & Development $2.123M $2.178M $2.762M
YoY Change -70.3% 174.48% 391.05%
% of Gross Profit
Depreciation & Amortization $101.4K $101.4K $101.4K
YoY Change 30.38% 31.98% -41.94%
% of Gross Profit
Operating Expenses $2.123M $2.178M $5.009M
YoY Change -88.23% 174.48% 276.6%
Operating Profit -$3.968M -$4.049M -$5.009M
YoY Change -74.03% 184.6%
Interest Expense $104.8K $8.370K $5.830K
YoY Change -537.01% -162.28% -255.05%
% of Operating Profit
Other Income/Expense, Net -$58.89K $8.370K $5.833K
YoY Change 457.68% -186.5%
Pretax Income -$4.027M -$4.040M -$5.004M
YoY Change -77.7% 182.1% 275.1%
Income Tax
% Of Pretax Income
Net Earnings -$4.027M -$4.040M -$5.004M
YoY Change -77.7% 182.1% 275.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.36 -$0.36 -$0.44
Diluted Earnings Per Share -$356.1K -$357.3K -$442.4K
COMMON SHARES
Basic Shares Outstanding 11.31M shares 11.31M shares 11.31M shares
Diluted Shares Outstanding 11.31M shares 11.31M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.796M $8.196M $12.62M
YoY Change 684.1%
Cash & Equivalents $9.796M $8.196M $12.61M
Short-Term Investments $0.00 $0.00 $930.00
Other Short-Term Assets $1.991M $1.766M $1.307M
YoY Change 8.37%
Inventory
Prepaid Expenses $1.991M $1.766M
Receivables $47.35K $140.1K $651.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.83M $10.10M $14.57M
YoY Change 241.81%
LONG-TERM ASSETS
Property, Plant & Equipment $2.851M $2.953M $3.859M
YoY Change -20.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.542M $3.702M $3.859M
YoY Change -0.95%
TOTAL ASSETS
Total Short-Term Assets $11.83M $10.10M $14.57M
Total Long-Term Assets $3.542M $3.702M $3.859M
Total Assets $15.38M $13.80M $18.43M
YoY Change 106.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $392.8K $282.3K $556.3K
YoY Change -64.92%
Accrued Expenses $670.7K $311.6K $1.059M
YoY Change -85.89%
Deferred Revenue
YoY Change
Short-Term Debt $5.000M $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $15.81K $15.57K $15.34K
YoY Change -93.28%
Total Short-Term Liabilities $6.406M $923.5K $1.631M
YoY Change -75.34%
LONG-TERM LIABILITIES
Long-Term Debt $25.59K $29.63K $33.61K
YoY Change -33.04%
Other Long-Term Liabilities $578.6K $665.8K $749.5K
YoY Change -33.65%
Total Long-Term Liabilities $604.1K $695.5K $783.1K
YoY Change -33.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.406M $923.5K $1.631M
Total Long-Term Liabilities $604.1K $695.5K $783.1K
Total Liabilities $7.010M $1.619M $2.414M
YoY Change -66.22%
SHAREHOLDERS EQUITY
Retained Earnings -$64.80M -$60.78M
YoY Change
Common Stock $1.131K $1.131K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.367M $12.18M $16.02M
YoY Change
Total Liabilities & Shareholders Equity $15.38M $13.80M $18.43M
YoY Change 106.26%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$4.027M -$4.040M -$5.004M
YoY Change -77.7% 182.1% 275.1%
Depreciation, Depletion And Amortization $101.4K $101.4K $101.4K
YoY Change 30.38% 31.98% -41.94%
Cash From Operating Activities -$3.400M -$4.412M -$3.864M
YoY Change 31.5% 36.82% 130.85%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$10.40K
YoY Change -100.0% -100.0% -84.35%
Acquisitions
YoY Change
Other Investing Activities $3.250K -$2.480K
YoY Change
Cash From Investing Activities $3.250K -$2.480K -$10.40K
YoY Change -120.61% -97.21% -84.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.996M -3.750K -3.680K
YoY Change 43.89% -100.12% -100.27%
NET CHANGE
Cash From Operating Activities -3.400M -4.412M -3.864M
Cash From Investing Activities 3.250K -2.480K -10.40K
Cash From Financing Activities 4.996M -3.750K -3.680K
Net Change In Cash 1.600M -4.418M -3.879M
YoY Change 83.66% 2781.08% 895.96%
FREE CASH FLOW
Cash From Operating Activities -$3.400M -$4.412M -$3.864M
Capital Expenditures $0.00 $0.00 -$10.40K
Free Cash Flow -$3.400M -$4.412M -$3.854M
YoY Change 32.31% 40.71% 139.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001862150
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
18882279 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2952920 usd
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3145378 usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
748782 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
usd
CING Property And Equipment Accrued But Not Yet Paid At End Of Period
PropertyAndEquipmentAccruedButNotYetPaidAtEndOfPeriod
usd
CY2021Q4 CING Prepaid Legal Fees
PrepaidLegalFees
usd
CY2022Q2 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
usd
CY2022Q2 CING Deferred Tax Assets Other Current
DeferredTaxAssetsOtherCurrent
usd
CY2022Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
usd
dei Document Type
DocumentType
10-Q
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
858600 usd
CY2022Q2 us-gaap Assets
Assets
13803854 usd
CY2021Q4 us-gaap Assets
Assets
22886257 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
282265 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
264687 usd
CY2021Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
usd
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
311573 usd
dei Entity File Number
EntityFileNumber
001-40874
dei Entity Registrant Name
EntityRegistrantName
Cingulate Inc.
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
601300 usd
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
15570 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
10102152 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1618980 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3825535
dei Entity Address Address Line1
EntityAddressAddressLine1
1901 W. 47th Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Kansas City
dei Entity Address State Or Province
EntityAddressStateOrProvince
KS
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
66205
dei City Area Code
CityAreaCode
(913)
dei Local Phone Number
LocalPhoneNumber
942-2300
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11309412 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8195760 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16492745 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
933 usd
CY2022Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
140113 usd
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
690248 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1766279 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1698353 usd
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
15096 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
314097 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
295595 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
923505 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1176678 usd
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
29633 usd
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
37534 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
665842 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
828503 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1396677 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4048817 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2042715 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4040447 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1432295 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
629032 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4117651 usd
us-gaap Net Income Loss
NetIncomeLoss
-9043958 usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11309412 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11309412 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11309412 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11309412 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1131 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1131 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
72963214 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
72574510 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3249 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
165 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60776222 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51732264 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
12184874 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20843542 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13803854 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22886257 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2178226 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
793587 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4940510 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1356106 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1870591 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1422619 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9058161 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2752783 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8370 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9676 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14203 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13435 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4040447 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1432295 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9043958 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2766218 usd
us-gaap Depreciation
Depreciation
202858 usd
us-gaap Depreciation
Depreciation
351286 usd
us-gaap Net Income Loss
NetIncomeLoss
-2766218 usd
us-gaap Share Based Compensation
ShareBasedCompensation
388705 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-550135 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
128528 usd
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-466 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3414 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
933 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
67926 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3415 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12882 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4040913 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1432295 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9047372 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2766218 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.80
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11309412 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11309412 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1292270 usd
CY2021Q1 CING Adjustments To Additional Paid In Capital Member Contributions
AdjustmentsToAdditionalPaidInCapitalMemberContributions
1385688 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1333923 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1344035 usd
CY2021Q2 CING Adjustments To Additional Paid In Capital Member Contributions
AdjustmentsToAdditionalPaidInCapitalMemberContributions
1987640 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1432295 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1899380 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20843542 usd
CY2022Q1 CING Unrealized Losses On Available For Sale Investments
UnrealizedLossesOnAvailableForSaleInvestments
-2948 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
181518 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5003511 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
16018601 usd
CY2022Q2 CING Unrealized Losses On Available For Sale Investments
UnrealizedLossesOnAvailableForSaleInvestments
-466 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
207186 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4040447 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
12184874 usd
us-gaap Net Income Loss
NetIncomeLoss
-9043958 usd
us-gaap Net Income Loss
NetIncomeLoss
-2766218 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1190416 usd
CING Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-109818 usd
CING Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
1739 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-272149 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
541672 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
18502 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
46732 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-162661 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-77501 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8276676 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3224712 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10400 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88955 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1698353 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88955 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
3373163 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7427 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
212853 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4821833 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7427 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3160310 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4811433 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1868913 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8296985 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1666055 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2952920 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-153357 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16492745 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1197672 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8195760 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1044315 usd
CING Property And Equipment Accrued But Not Yet Paid At End Of Period
PropertyAndEquipmentAccruedButNotYetPaidAtEndOfPeriod
164365 usd
us-gaap Interest Paid Net
InterestPaidNet
9619 usd
us-gaap Interest Paid Net
InterestPaidNet
4880 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3145378 usd
us-gaap Depreciation
Depreciation
202858 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zbEAkleGLmji" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_z3N5whGRf5e6">Concentration of Credit Risk</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash equivalent deposits, which at various times throughout the fiscal year exceeded the amounts insured by the Federal Deposit Insurance Corporation limit of $<span id="xdx_90E_eus-gaap--TimeDepositsAtOrAboveFDICInsuranceLimit_iI_c20220630_zyAP5CAn9gM4" title="Federal deposit insurance corporation limit">250,000</span> (without regard to reconciling items). Management monitors the soundness of these financial institutions and does not believe the Company is subject to any material credit risk relative to the uninsured portion of the deposits.</span></p>
CY2022Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
us-gaap Depreciation
Depreciation
351286 usd
CY2022Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2021Q2 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1201974 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1766279 usd
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
74615 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
49606 usd
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
1137786 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
761594 usd
CY2022Q2 CING Prepaid Active Pharmaceutical Ingredients
PrepaidActivePharmaceuticalIngredients
224381 usd
CY2021Q4 CING Prepaid Active Pharmaceutical Ingredients
PrepaidActivePharmaceuticalIngredients
264361 usd
CY2022Q2 CING Prepaid Research And Development
PrepaidResearchAndDevelopment
116432 usd
CY2021Q4 CING Prepaid Research And Development
PrepaidResearchAndDevelopment
643917 usd
CY2022Q2 CING Prepaid Legal Fees
PrepaidLegalFees
154858 usd
CY2022Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
132822 usd
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
28481 usd
CY2022Q2 us-gaap Depreciation
Depreciation
101429 usd
CY2021Q2 us-gaap Depreciation
Depreciation
76853 usd
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-497189 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
15000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
15000 usd
CY2022Q2 CING Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
250000 usd
CY2021Q4 CING Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
250000 usd
CY2021Q4 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
279730 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
46573 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
56570 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
311573 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
601300 usd
CY2021Q2 us-gaap Preferred Units Issued
PreferredUnitsIssued
948804 shares
CY2022Q2 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-223432 usd
CING Income Tax Reconciliation Permanent Difference
IncomeTaxReconciliationPermanentDifference
8763 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11309412 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11309412 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11309412 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11309412 shares
CY2022Q2 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-848475 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3666781 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1357945 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0160 pure
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y25D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.0112 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
1.46
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1888057 usd
CY2022Q2 CING Income Tax Reconciliation Permanent Difference
IncomeTaxReconciliationPermanentDifference
3098 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2439294 usd
CY2022Q2 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1077408 usd
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-62811 usd
CY2022Q2 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-8599 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3285986 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
847269 usd
CY2022Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
962910 usd
CY2022Q2 CING Deferred Tax Assets Unvested Stock Options
DeferredTaxAssetsUnvestedStockOptions
116786 usd
CY2021Q4 CING Deferred Tax Assets Unvested Stock Options
DeferredTaxAssetsUnvestedStockOptions
11835 usd
CY2021Q4 CING Deferred Tax Assets Other Current
DeferredTaxAssetsOtherCurrent
4050 usd
CY2022Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
102317 usd
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
90480 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2410153 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3285986 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
847269 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
380795 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5883799 shares
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
510676 usd
CY2022Q2 CING Deferred Tax Liabilities Accrual To Cash Current
DeferredTaxLiabilitiesAccrualToCashCurrent
29963 usd
CY2021Q4 CING Deferred Tax Liabilities Accrual To Cash Current
DeferredTaxLiabilitiesAccrualToCashCurrent
105075 usd
CY2021Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
9000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
350832 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
405601 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
380795 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
510676 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4040447 usd
us-gaap Net Income Loss
NetIncomeLoss
-9043958 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11309412 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11309412 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.80
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5883799 shares
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
18000 usd
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
18000 usd
CY2022Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
9000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd

Files In Submission

Name View Source Status
0001493152-22-021964-index-headers.html Edgar Link pending
0001493152-22-021964-index.html Edgar Link pending
0001493152-22-021964.txt Edgar Link pending
0001493152-22-021964-xbrl.zip Edgar Link pending
cing-20220630.xsd Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
cing-20220630_lab.xml Edgar Link unprocessable
cing-20220630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cing-20220630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cing-20220630_cal.xml Edgar Link unprocessable